Phenotyping and Genotyping Studies of Thiopurine S-methyltransferase in Kazaks.

Hong Wei,Shufeng Zhou,Chengrong Li,Jianping Zhang,Jueheng Wu,Min Huang
DOI: https://doi.org/10.1007/s11095-005-7095-1
IF: 4.58
2005-01-01
Pharmaceutical Research
Abstract:OBJECTIVE:This study was conducted to investigate the thiopurine S-methyltransferase (TPMT) activity distribution and gene mutations in Kazaks, and compared the results with those of other ethnic groups.METHODS:Erythrocyte TPMT activity was measured in Kazaks (n = 327) via a validated high-performance liquid chromatography assay. Polymerase chain reaction-based methods were used to analyze three commonly reporter-inactivating mutations: G238C, G460A, and A719G.RESULTS:Unimodal distribution of TPMT activity was found in Kazaks. Six TPMT*3C heterozygotes and two TPMT*3A heterozygotes were found in 327 Kazaks, with allele frequencies of 0.9 and 0.3%, respectively. The subjects with TPMT*3A and TPMT*3C heterogygotes had substantial TPMT activity over the range of 6.40-11.75 U/ml RBC.CONCLUSION:Unlike in most Caucasians, TPMT*3C is a common mutant allele in Kazaks, whereas TPMT*3A is a rare mutant allele. Further studies are needed to explore the clinical impact of these TPMT mutants to thiopurine therapy in Kazak patients.
What problem does this paper attempt to address?